| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/29/1999 | WO1999037333A1 Method for removing and/or inactivating viruses |
| 07/29/1999 | WO1999037332A1 Bone cancer therapy |
| 07/29/1999 | WO1999037329A1 Pharmaceutical formulation comprising an antibody and a citrate buffer |
| 07/29/1999 | WO1999037328A1 Preventives/remedies for aids |
| 07/29/1999 | WO1999037326A1 Biologically active hemagglutinin from type a clostridium botulinum and methods of use |
| 07/29/1999 | WO1999037325A2 Method for treating acute intermittent porphyria (aip) and other porphyric diseases |
| 07/29/1999 | WO1999037322A1 Method of using il-11 to enhance cell mediated immunity for treating various viral and parasitic infections and cancer |
| 07/29/1999 | WO1999037321A1 Immuno-modulating preparation containing interleukin-1 and method for preparing the same |
| 07/29/1999 | WO1999037320A1 Methods and compositions for enhancing cognitive function using morphogenic proteins |
| 07/29/1999 | WO1999037319A1 Method for treating inflammatory diseases using heat shock proteins |
| 07/29/1999 | WO1999037318A1 Histone containing composition to treat rheumatoid arthritis |
| 07/29/1999 | WO1999037317A1 Artificial proteoglycans |
| 07/29/1999 | WO1999037315A1 Chemical derivatives of autoantigens and autoimmune-suppressive peptides and pharmaceutical composition containing the same |
| 07/29/1999 | WO1999037314A1 Sea cucumber carotenoid lipid fraction products and methods of use |
| 07/29/1999 | WO1999037299A1 Use of inhibitors for the treatment of disorders related to rtk hyperfunction, especially cancer |
| 07/29/1999 | WO1999037167A2 Process of improving the stability of vitamin d in a nutritional product containing hydrolyzed protein and product produced thereby |
| 07/29/1999 | WO1999037149A1 Methods of treating cytotoxic damage |
| 07/29/1999 | WO1999031227A3 NOVEL PEPTIDE, apoEp1.B, COMPOSITIONS AND USES THEREOF |
| 07/29/1999 | WO1999020755A3 Novel cytokine receptors |
| 07/29/1999 | WO1999019476A3 NON-MAMMALIAN MESODERM INDUCTION EARLY RESPONSE (nm-MIER) GENE FAMILY |
| 07/29/1999 | WO1999018956A9 12(s)-hete receptor blockers |
| 07/29/1999 | WO1999012968A3 Chemokine peptides, variants, derivatives and analogs, their use in methods to inhibit or augment an inflammatory response |
| 07/29/1999 | WO1998059063A3 Bovine adenovirus type 3 genome |
| 07/29/1999 | WO1998050530A3 Enzymatic nucleic acids: synthesis, selection and use |
| 07/29/1999 | WO1995030750A8 Lag-3 protein soluble polypeptide fractions, method of production, therapeutic composition and anti-idiotype antibody |
| 07/29/1999 | DE19802792A1 Inhibiting DNA modulation caused by p53 mutant, useful for treatment of cancer |
| 07/29/1999 | DE19802375A1 Removal and/or inactivation of virus in blood products |
| 07/29/1999 | DE19801438A1 Use of phosphodiesterase (PDE) inhibitors to improve sperm motility in insemination and in-vitro fertilization procedures |
| 07/29/1999 | CA2320624A1 Mutants of il-16, processes for their production, and their use |
| 07/29/1999 | CA2319210A1 Cubilin protein, dna sequences encoding cubilin and uses thereof |
| 07/29/1999 | CA2319208A1 Orphan receptors |
| 07/29/1999 | CA2319207A1 Peptides with .beta.1 integrin subunit dependent cell adhesion modulating activity |
| 07/29/1999 | CA2319160A1 Monoclonal antibody anti .alpha.v-integrin and its use to inhibit .alpha.v.beta.6-integrin attachment to fibronectin |
| 07/29/1999 | CA2319158A1 Process of improving the stability of vitamin d in a nutritional product containing hydrolyzed protein and product produced thereby |
| 07/29/1999 | CA2319121A1 Use of inhibitors for the treatment of rtk-hyperfunction-induced disorders, particularly cancer |
| 07/29/1999 | CA2319115A1 Methods for identifying antimicrobial peptides that interact with enoyl acp reductase |
| 07/29/1999 | CA2319113A1 Biologically active hemagglutinin from type a clostridium botulinum and methods of use |
| 07/29/1999 | CA2319109A1 Meth1 and meth2 polynucleotides and polypeptides |
| 07/29/1999 | CA2319076A1 Expression of the insl4 gene in human embryonic bone tissues and applications |
| 07/29/1999 | CA2319000A1 Prostheses with associated growth factors |
| 07/29/1999 | CA2318935A1 Phagocytosis genes and uses thereof |
| 07/29/1999 | CA2318816A1 Ligand receptors and uses therefor |
| 07/29/1999 | CA2318743A1 Novel molecules of the tnf receptor superfamily and uses therefor |
| 07/29/1999 | CA2318382A1 Method of using il-11 to enhance cell mediated immunity for treating various viral and parasitic infections and cancer |
| 07/29/1999 | CA2318352A1 Diagnosis and treatment of aur1 and/or aur2 related disorders |
| 07/29/1999 | CA2318313A1 Inhibition of dna modulation caused by mutated p53 |
| 07/29/1999 | CA2318303A1 Secreted proteins and polynucleotides encoding them |
| 07/29/1999 | CA2318263A1 Method for treating inflammatory diseases using heat shock proteins |
| 07/29/1999 | CA2317920A1 Human calcineurin b-like protein |
| 07/29/1999 | CA2317839A1 Inhibition of cytokine production |
| 07/29/1999 | CA2317761A1 Thrombin inhibitors |
| 07/29/1999 | CA2317727A1 Multipurpose antibody derivatives |
| 07/29/1999 | CA2317492A1 Isolated, polypeptides which bind to hla-a29 molecules, nucleic acid, the molecules encoding these, and uses thereof |
| 07/29/1999 | CA2260610A1 Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof |
| 07/28/1999 | EP0931836A1 Vasopermeability enhancing peptide of human interleukin-2 and immunoconjugates thereof |
| 07/28/1999 | EP0931832A1 Metalocarboxypeptidase inhibitors and derived molecules used as antitumor agents |
| 07/28/1999 | EP0931793A1 Monoclonal antibody specific for the activated coagulation factor VII (FVIIa) and its use |
| 07/28/1999 | EP0931792A1 Depsipeptides containing non-natural amino acids |
| 07/28/1999 | EP0931786A2 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
| 07/28/1999 | EP0931551A1 Diagnostics and therapeutics for transmissible spongiform encephalopathy and method for the manufacture of non-infective blood products and tissue derived products |
| 07/28/1999 | EP0931159A2 Non-mammalian dna virus having an altered coat protein |
| 07/28/1999 | EP0931149A2 A novel haemopoietin receptor and genetic sequences encoding same |
| 07/28/1999 | EP0931148A1 Fibroblast growth factor homologs |
| 07/28/1999 | EP0931147A1 ANTI-ErbB2 ANTIBODIES |
| 07/28/1999 | EP0931145A1 Ptx sensitive g proteins, the production and use thereof |
| 07/28/1999 | EP0931144A1 Novel human phospholemman-like protein |
| 07/28/1999 | EP0931138A1 Method of producing a thymic microenvironment that supports the development of dendritic cells |
| 07/28/1999 | EP0931096A2 HT m4?, METHODS OF TREATMENT AND ASSAYS, AGONISTS AND ANTAGONISTS |
| 07/28/1999 | EP0931095A2 Novel human lim proteins |
| 07/28/1999 | EP0931092A2 Variants of vascular endothelial cell growth factor having antagonistic properties |
| 07/28/1999 | EP0931091A1 Inhibitors of pla 2 |
| 07/28/1999 | EP0930893A1 Immunostimulatory polynucleotide/immunomodulatory molecule conjugates |
| 07/28/1999 | EP0930892A1 Cytokine enhanced immunotherapy for brain tumors |
| 07/28/1999 | EP0930891A1 Oral administration of chicken yolk antibodies to treat disease |
| 07/28/1999 | EP0930890A1 USE OF FasL OR FasL TRANSFECTED CD4?+ /FasL?- /TH1-CELL LINES FOR THE TREATMENT OF TH1/TH2 DISEASES |
| 07/28/1999 | EP0930882A2 Prevention or treatment of type 2 diabetes or cardiovascular disease with ppar modulators |
| 07/28/1999 | EP0874639A4 Peptide inhibitors of a phosphotyrosine-binding domain containing protein |
| 07/28/1999 | EP0743958A4 Non-viral vector |
| 07/28/1999 | EP0678122B1 Recombinant anti-vla4 antibody molecules |
| 07/28/1999 | EP0621902B1 Dna structure-specific recognition protein and uses therefor |
| 07/28/1999 | EP0565604B1 Catheter for drug delivery system |
| 07/28/1999 | EP0546119B1 Cell density signal molecule isolated from embryonic tendon cells |
| 07/28/1999 | EP0538401B1 Novel receptor-type phosphotyrosine phosphatase |
| 07/28/1999 | CN1224465A Use of interleukin-10 to produce population of suppressor cells |
| 07/28/1999 | CN1224464A Growth factor and genetic sequence encoding same |
| 07/28/1999 | CN1224430A Methods of alleviating neuropathic pain using prosaposin-derived peptides |
| 07/28/1999 | CN1224359A Lactoferrtin variants and uses thereof |
| 07/28/1999 | CN1224358A Non-aqueous polar aprotic peptide formulations |
| 07/28/1999 | CN1224357A Aqueous formulations of peptides |
| 07/28/1999 | CN1224356A Non-aqueous protic peptide formulations |
| 07/28/1999 | CN1224353A Virginiamycin mixture |
| 07/28/1999 | CN1224347A High dose liposomal aerosol formulations |
| 07/28/1999 | CN1223888A Anticancer oral liquid contg. lipolytic enzyme |
| 07/28/1999 | CN1223887A Carcinolysin |
| 07/28/1999 | CN1223877A Medicinal liquor for treatment of atrophic debility of bone and eliminating wind |
| 07/28/1999 | CA2221826A1 Peptide t and related peptides in the treatment of htlv-1 myelopathy and multiple sclerosis |
| 07/27/1999 | USRE36259 Treating with sodium caprylate and ethanol, diafiltering |
| 07/27/1999 | US5929304 Used for enzyme replacement therapy for the therapeutic treatment of human and animal lysosomal storage diseases |
| 07/27/1999 | US5929237 Conformationally constrained compounds which mimic the secondary structure of reverse-turn regions of biologically active peptides and proteins; for random drug screening |
| 07/27/1999 | US5929225 Human gene homologous to bacterial gene controlling sensitivity to methyl methane sulfonate; anticarcinogenic agents; for repairing alkylated nucleic acids; for treating cell death; antagonists to prevent tumor nucleic acid repair |